Found 36 articles for: "Inflammatory"
Post-Inflammatory Hyperpigmentation in Skin of Color Patients With Atopic Dermatitis
October 2026 | Volume 25 | Issue 10 | Features | 975 | Copyright © October 2026
Assessing the Variability of Dermatologic Needs in American Indian/Alaskan Native Populations: A Single-Center Retrospective Analysis
October 2026 | Volume 25 | Issue 10 | Editorials | e59 | Copyright © October 2026
Improvement of Rosacea With Tirzepatide: A Case Report
August 2026 | Volume 25 | Issue 8 | Case Reports | 749 | Copyright © August 2026
Hidradenitis Suppurativa in Psoriasis Patients Treated With Biologics
August 2026 | Volume 25 | Issue 8 | Editorials | e75 | Copyright © August 2026
Biologics for Pediatric Hidradenitis Suppurativa: An Update on the Evolving Therapeutic Landscape
August 2026 | Volume 25 | Issue 8 | Features | 765 | Copyright © August 2026
Efficacy and Tolerability of a Topical Pigment-Correcting Serum in Melasma and Postinflammatory Hyperpigmentation
July 2026 | Volume 25 | Issue 7 | Original Article | 596 | Copyright © July 2026
Read More1927 nm Diode Laser for Infraorbital Hyperpigmentation in Skin of Color: Safe and Effective Approach
July 2026 | Volume 25 | Issue 7 | Features | 666 | Copyright © July 2026
Background: Infraorbital hyperpigmentation (IOH) is a common aesthetic concern with multifactorial pathogenesis, especially prevalent in patients with skin of color (SOC). Its ma...
Read MoreRacial Differences in Secondary Skin Complications and Timing of Topical Therapy Initiation for Pseudofolliculitis Barbae: A Multicenter Retrospective Database Cohort Study
July 2026 | Volume 25 | Issue 7 | Editorials | e69 | Copyright © July 2026
A Novel Retinoid and Salicylic Acid Topical Treatment for Moderate-Severe Acne
June 2026 | Volume 25 | Issue 6 | Original Article | 558 | Copyright © June 2026
Background: Advances in biotechnology have enabled highly effective, site-specific topical therapies for skin disease. Particle-based delivery systems can be engineered with tail...
Read MorePatients With Lichen Planopilaris Are at Increased Risk of Skin Cancer
May 2026 | Volume 25 | Issue 5 | Features | 479 | Copyright © May 2026
Treatment or Trigger? The Use of Biologic Therapy for Alopecia Areata
May 2026 | Volume 25 | Issue 5 | Features | 489 | Copyright © May 2026
An Investigator-Developed Regimen for Treatment and Prevention of Post-Inflammatory Hyperpigmentation in Skin of Color
April 2026 | Volume 25 | Issue 4 | Original Article | 330 | Copyright © April 2026
Background: There is an unmet demand for a post-inflammatory hyperpigmentation (PIH) treatment and prevention that is not only effective and accessible, but also safe to use in d...
Read MoreHydroquinone and Emerging Depigmenting Agents: Clinical Guidelines, Regulatory History, and Global Safety Considerations
April 2026 | Volume 25 | Issue 4 | Original Article | 363 | Copyright © April 2026
Hydroquinone has long served as the gold standard for hyperpigmentation treatment, but safety concerns, regulatory changes, and growing interest in non-hydroquinone therapies have prompted reeval...
Read MoreRapid Clearance of Lichen Planus With Topical Tapinarof
April 2026 | Volume 25 | Issue 4 | Case Reports | 381 | Copyright © April 2026
Background: Lichen planus (LP) is an auto-inflammatory idiopathic condition affecting skin, mucous membranes, hair follicles, and nails that presents as pruritic, violaceous papu...
Read MoreEvaluating the Risk of Atherosclerotic Cardiovascular Disease in Inflammatory Skin Disease: Insights From a TriNetX Cohort Study
December 2025 | Volume 24 | Issue 12 | Original Article | 1181 | Copyright © December 2025
Objective: Recognizing the risk of atherosclerotic cardiovascular disease (ASCVD) in patients is crucial in clinical practice. Recent studies suggest an association between infla...
Read MoreNourishing the Skin: A Review of Diet's Role in Hidradenitis Suppurativa
November 2025 | Volume 24 | Issue 11 | Original Article | 1103 | Copyright © November 2025
Hidradenitis suppurativa (HS) is a complex skin condition influenced by both genetic and environmental factors. Increasing evidence points to diet as a key contributor to disease severity through...
Read MoreConnecting the Plaques: Exploring the Link Between Dupilumab and Cutaneous T-cell Lymphoma
November 2025 | Volume 24 | Issue 11 | Features | 1148 | Copyright © November 2025
The Role of Simultaneous Janus Kinase Inhibitor and Biologic Therapy Use for Refractory Atopic Dermatitis
October 2025 | Volume 24 | Issue 10 | Case Reports | 1043 | Copyright © October 2025
Beyond Inflammation and Itch: A Call for a Broader Framework in Atopic Dermatitis
October 2025 | Volume 24 | Issue 10 | Editorials | e62 | Copyright © October 2025
Cannabidiol in Dermatology: Progress and Pitfalls
September 2025 | Volume 24 | Issue 9 | Features | 957 | Copyright © September 2025
© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.
